Global HIP Replacement Devices Market Trends and Industry Analysis Report 2018

According to the new market research report "Hip Reconstruction Devices Market by Product (Primary Hip Reconstruction Devices (Cemented, Cementless), Partial Hip Reconstruction Devices, Revision Hip Reconstruction Devices, HIP Resurfacing), Geography (Americas, EU-5, Japan, BRIC, South-East Asia, MEA) - Forecast", published by MarketsandMarkets™, is estimated to reach USD 5.9 Billion, at a CAGR of 3.0%

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?
id=76831539

 The government initiative of allocating new funds and development of new policies have reduced the waiting time for hip reconstructions, and increased the number of operations. However, it is difficult to achieve 90% threshold of patients that receive care within the regulated time. The technological advancements in hip reconstruction market, such as newly developed prostheses with improved strength and reliability of joints are reducing the need and cost of revision surgery. The minimally invasive techniques for hip reconstruction surgery will improve the precision and accuracy of surgeons, thus reducing the time of surgery. The emergence of these techniques and other improved surgical tools for the treatment of arthritis is expected to address the rising demand for surgery during the forecast period.

Browse and in-depth TOC on "Hip Reconstruction Devices Market" 
105 - Tables
114 -  Figures 
228 - Pages 

In 2014, the global hip reconstruction devices market was dominated by North America. This market is segmented and forecast on the basis of product, and geography. The product comprises of primary hip reconstruction devices, partial hip reconstruction devices, revision hip reconstruction devices and hip resurfacing devices.

The primary hip reconstruction devices are subsegmented into cementless and cemented reconstruction device. The market is further segmented and forecast on the basis of major geographies such as North America, Europe, and Asia-Pacific. These major geographies are further sub-segmented into major countries.

The market in North America is growing due to rising pool of arthritis, and favorable reimbursement. The European market is growing due to the technological advancements and is dominated majorly by Zimmer Inc. (U.S.) and Depuy Synthes (U.S.). The Asian market is growing due to growing health awareness among masses, along with increase in the spending capacity of the Indian population. Also, increasing number of population suffering from musculoskeletal disorders (MSD), government initiatives, and rising awareness towards hip reconstruction are propelling the market growth. 

Request for Free Sample Report @ https://www.marketsandmarkets.com/requestsample.asp?id=76831539

The research study is aimed at identifying emerging trends and opportunities in the global hip reconstruction devices market along with detailed classifications, in terms of revenue. It provides comprehensive competitive landscape and identifies the key players with respect to market size and market share. The research study also includes a detailed segmentation of the global hip reconstruction devices market, on the basis of product, and region.

Global Medical Automation Market 2019: Industry Analysis, Size, Share, Revenue and Forecast

The Continuous technological advancements in automation solutions, increasing government financial support for medical automation, rising labour costs, and growing need for reproducibility and accuracy are key factors fuelling the growth of the medical automation market. Increasing demand for automation in laboratories and pharmacies and high potential for early detection and treatment of diseases due to automation are some other prime factors offering growth opportunities for players in the market. However, high cost of automation is one of the key restraints for this market.

According to the new market research report "Medical Automation Market by Application (Diagnostics & Monitoring, Therapeutics, Lab & Pharmacy Automation, Medical Logistics & Training), End-User (Hospital, Diagnostic Center, Research Institute, Home/Ambulatory Care) - Global Forecast", published by MarketsandMarkets™.

Revenue Growth Opportunities:

Medical Automation Market is projected to reach USD 55.03 Billion, at CAGR of 9.5%

Market Segmentation in-Detailed:-

On the basis of application, the market is divided into four major segments, namely, diagnostic and monitoring automation (automated imaging, automated image analysis, and point-of-care testing), therapeutic automation (non-surgical automation and surgical automation), laboratory and pharmacy automation (laboratory automation and pharmacy automation), and medical logistics and training (logistics automation and trainers).

The therapeutic automation segment is estimated to hold the largest share of the global medical automation market. Increasing application of automated devices (such as defibrillators, surgical robots, surgical navigation systems, and automated medication systems) in therapeutics and rising incidences of various chronic diseases are driving the growth of this market segment.

On the basis of end users, the global market is divided into four segments, namely, hospitals and diagnostic centers, pharmacies, research laboratories and institutes, and home/ambulatory care settings and other end users.

Download PDF (Please provide your specific interest in this report so as to help you better): https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=848

Worldwide Geographical Segmentation in-detailed:

The Medical Automation therapy market is segmented into four regional segments, namely, North America, Europe, the Asia Pacific, and the Rest of the World. North America is estimated to hold the largest share of the global market, followed by Europe. However, the Asia-Pacific market is expected to grow at the highest CAGR of 11.6% from 2015 to 2020. Presence of a large geriatric population; increasing prevalence of CVDs, diabetes, and cancer; rising number of clinical research activities; and growing government expenditure on healthcare and life sciences research are propelling the growth of the Asia-Pacific market.

Emerging Asia-Pacific countries, including India and China, offer high growth potential for companies engaged in the development and marketing of automated solutions for the healthcare industry.

Request Research Sample Pages:

https://www.marketsandmarkets.com/requestsampleNew.asp?id=848

Leading Key Players in the Worldwide Industry:

The major players operating in the Medical Automation Market are Koninklijke Philips N.V. (Netherlands), Siemens AG, (Germany), General Electric Company (U.S.), Medtronic plc. (U.S.), Tecan Group Ltd. (Switzerland), Intuitive Surgical, Inc. (U.S.), Stryker Corporation (U.S.), Accuray Incorporated (U.S.), Danaher Corporation (U.S.), and Swisslog Holding AG (Switzerland)

Biobanking Market Forecast 2024, opportunities with Huge Profit and Marginal Revenue

Biobanking Market plays an integral role in advancing biomedical and translational research, through the collection and preservation of biological samples, such as blood, tissues, and nucleic acids, which are then made available for use in research to discover disease-relevant biomarkers; this is further used for diagnosis, prognosis, and predicting drug responses. Growth in the number of research activities in this segment forms a major driver for the market.

The availability of government funding for regenerative medicine, stem cell therapeutics, and cell & gene therapy is supporting research activities in this segment. Apart from this, the increasing trend of cord blood banking will also aid the growth of this market segment. Prospects including advancements in orthopedic procedures with the use of stem cells are expected to further support market growth for regenerative medicine.

Worldwide Growth Opportunities in Terms of Revenue & Segmentation:

The Biobanking Market is expected to reach $2.69 billion, Nearly at a CAGR of 7.8%. 

The Global market is segmented by product and service, sample type, storage type, application and regions.

By product and service, the market is segmented into equipment, consumables, services and software. The equipment segment is expected to lead the global market. Factors such as the growth in the number of biobanks and the number of biosamples to be stored are increasing the demand for biobanking devices market.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=594

By sample type, the Biobanking Market is classified into blood products, human tissues, cell lines, nucleic acids, human waste products, and biological fluids. Since blood and blood products are the most collected specimens and are used as a source of DNA and RNA, this segment type holds the largest share of the biobanking devices market.

On the basis of applications, the market is segmented into regenerative medicine, life science research, and clinical research. Regenerative Medicine is expected to account for the largest share of the market based on applications. Growing research in regenerative medicine and the increasing demand for well-characterized and quality biosamples for research are prime reasons for the growth of this market segment.

Global Geographical Analysis for Biobanking Market:

The Global market is dominated by North America, followed by Europe. North America will continue to dominate the global market in the forecast period. However, Asia-Pacific is expected to witness the highest CAGR, with the growth in this market centered at Japan, China, and India. Improving life sciences research infrastructure in emerging economies and growing government investment in biomedical, pharmaceutical, and biotechnology industries are some of the factors propelling market growth in the Asia-Pacific region.

Request Research Sample Pages:

https://www.marketsandmarkets.com/requestsampleNew.asp?id=594

The Major Factors Driving the Growth of Biobanking Market:

·         Increase in Genomic Research Activities for Studying Diseases

·         Advances in Biobanking and Growing Trend of Conserving Cord Blood Stem Cells of Newborns

·         Government and Private Funding to Support Regenerative Medicine Research

·         Growing Need for Cost-Effective Drug Discovery and Development

Major Key Players in Global Biobanking Market:

Key players in the market includes Hamilton Company (U.S.), Thermo Fisher Scientific Inc. (U.S.), Brooks Automation (U.S.), and Panasonic Healthcare Holdings Co. Ltd (Japan) have been identified as the top players in this market. These companies have a broad product portfolio with comprehensive features and have also launched innovative products. These leaders also have products for all end users in this market, a strong geographical presence, and they focus on continuous product innovations.

Cancer Diagnostics Market 2019 Key highlights, Segmentation, Overview and Forecast

The Research Report on Cancer Diagnostics Market Consist 89 market data tables and 37 figures spread through 197 pages and in-depth TOC, which covers Global Market overview, Major Key Players detailed Analysis, market opportunities, market risk, forecast for the next five years, major driving factors for the market as well as detailed analysis for CAGR, scope, research findings, leading key players marketing strategy to acquire major market in the form of revenue.

The cancer diagnostics market is highly competitive with many big and small players operating in different market segments.

Technological advancements in various fields such as biomarkers, imaging, biopsy, endoscopy; growing number of cancer cases, rapidly rise in geriatric population, awareness initiatives by governments, and increasing government funding are major factors driving the market growth. However, high capital investment and low benefit-cost ratio of biomarkers and dearth of skilled professionals pose restraints to the growth of this market. Improving healthcare infrastructure in emerging countries and growing demand of companion diagnostics offer growth opportunities for this market.

The global cancer diagnostics market is segmented based on technology, application, and region.

Download PDF (cancer diagnostics):

https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=186559121

The platform-based technology is further segmented into next-generation sequencing, microarrays, PCR, flow cytometry, in situ hybridization, immunohistochemistry, and others. Instrument-based cancer diagnostics is further segmented into imaging systems and biopsy.

Market-by Application

·         Breast Cancer

·         Lung Cancer

·         Colorectal Cancer

·         Melanoma

Cancer Diagnostics Market, by Product

# Platform-based

-          Next-generation Sequencing

-          Microarrays

-          PCR

-          Flow Cytometry

# Instrument-based

-          Imaging Instruments

-          Ultrasound

-          Mammography

Request Research Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=186559121

Based on region, the market is divided into North America, Europe, Asia, and Rest of the World (RoW). Rest of the World comprises Latin America, Pacific countries, and Middle East and Africa. North America is expected to account for the largest share in the cancer diagnostics market, followed by Europe and Asia. However, the Asian market is slated to grow at the highest CAGR in the coming five years and serves as a revenue pocket for the companies operating in the market.

Some of the major players in the global market include Agilent Technologies, Inc. (U.S.), Thermo Fisher Scientific, Inc. (U.S.), Illumina, Inc. (Denmark), Becton, Dickinson and Company (U.S.), GE Healthcare (U.K.), QIAGEN N.V.  (Netherlands), Abbott Laboratories, Inc. (U.S.), Roche Diagnostics (Switzerland), Siemens Healthcare (Germany), Philips Healthcare (U.K.), and C.R. Bard, Inc. (U.S.)

European Healthcare EDI Market 2018 Analysis, Key Players, Size, Growth Rate and Forecast

EDI is increasingly being adopted in the European Healthcare EDI Market; this industry is expected to register significant growth due to greater uptake of EDI solutions among pharmaceuticals and medical device companies owing to various advantages such as reduction in the administration costs, reduced errors, pricing pressure, and lower profit margins. Moreover, the increasing number of government initiatives toward the implementation of IT in the healthcare industry is estimated to propel the demand for healthcare IT solutions, which in turn will drive the healthcare EDI market.

However, high cost of EDI implementation, challenges in management of EDI, security concerns of the data and restricted investments in healthcare EDI by hospitals present challenges to the overall growth of the market. The increasing use of EDI in healthcare manufacturing & distribution industry and gradual acceptance of mobile EDI are the major trends in the EDI market.

In this report, the European Healthcare EDI Market is segmented based on type of transaction, type of purchasing organization, and region. ORDERS was the most preferred transaction type, followed by INVOIC in European healthcare system. In terms of volume, in 2015, approximately 51.2 million purchase orders were generated by hospitals in Germany through EDI. The increasing number of hospitals in Europe adopting EDI solutions especially in supply chain management due reduced errors enabling operational benefits, less errors, faster transaction processing, and various government initiatives are the key factors contributing to the growth of healthcare EDI market in Europe.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=93400242

The European Healthcare EDI Market is growing at a fast pace. Europe is one of the major markets for the use of EDI in healthcare supply chain. Pharmaceutical wholesalers were early adopters of EDI in Europe, and currently process nearly 92%–95% of their orders through EDI. Due to growing competition and decreasing profit margins, pharmaceutical companies and medical device manufacturers in Europe are under increasing pressure to implement EDI systems that help them cut operating costs and remain competitive and profitable. ORDERS, DESADV, and INVOIC are the most preferred EDI transaction types for supply chain management in hospitals across Europe.

EDI primarily focuses on the electronic exchange of business transactions such as purchase orders, shipment authorizations, shipment acknowledgements, advanced shipment notices, or invoices. EDI provides a fast, secure, and easy exchange of information between healthcare organizations. Most of the hospitals in Europe are focusing on deploying a full suite of electronic processes with automated methods to track the complete process of purchase order purchase order acknowledgement, invoice creation/matching, and processing to the accounts payable system.

Request Research Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=93400242

Geographically, the European Healthcare EDI Market is analyzed at the country level, comprising Benelux, Denmark, France, Germany, Italy, Spain, Sweden, Switzerland, and the U.K. Germany, France, Denmark, Sweden are expected to witness a high penetration rate for healthcare EDI in coming years owing to the rising geriatric population, increasing government funding and initiatives, improving healthcare infrastructure, increasing demand for quality healthcare at low costs, and presence of major companies in these regions.

Bayer AG, Pfizer Inc., GlaxoSmithKline PLC, and Abbott Laboratories are the EDI technology leaders in the pharmaceutical and manufacturing sector in Europe.

Medical Robots Transforming Healthcare Market - Growth by Top Key Players and Forecast Analysis

The Research Report analyzes and studies the price variation in medical robots of varied types (surgical/rehabilitation/non-invasive radiosurgery/hospital & pharmacy), selection criteria of adopting medical robots from an end-user perspective, buying a cycle, price wars, and cost-benefits offered by the robots based on existing research studies.

According to the new market research report “Medical Robots Transforming Healthcare: Pricing & Cost-Benefit Assessment (Price Variation (by Product (Surgical Robots, Rehabilitation Robotics, Stereotactic Radiosurgery), by Application, by Geography), Reimbursement, Selection Criteria, Buying Cycle”, published by MarketsandMarkets™

Download PDF - Please share your specific interest to serve you better.@ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=66468116

Medical robots are devices that are used to improve the quality of care for patients. The major types of medical robots are surgical robots, hospital and pharmacy robots, rehabilitation robots, and non-invasive radiosurgery robots. Each type of robots varies widely in prices, offer varied benefits & cost-saving advantages, and are subject to different reimbursement structures, buying a cycle, price wars, and other factors.

Browse and in-depth TOC on “Medical Robots Transforming Healthcare Market”
33 — Tables
21 — Figures
97 — Pages

The other factors that influence the robot prices include discounts offered, supply chain mark-ups, reimbursements, and price war. The study elaborates on each of these factors and their association with price variation of different robot types.

The research findings cited in the report encapsulates the buying cycle and the key decision makers for the purchase of a robot. Selection criteria considered by end-user for embracing medical robots is also included in the scope of the study. Additionally, the marketing & promotional strategies focused by the vendors and financing options offered throws light on activities focused by vendors to increase customer access to the highly sophisticated technology.

Marketing and promotion was the dominant strategy adopted by players in the medical robotics market. This strategy was employed by players to increase the awareness of their products and educate potential clientele on the use and benefits of their products.

Request Research Sample Pages:

https://www.marketsandmarkets.com/requestsampleNew.asp?id=66468116

Furthermore, a separate section on cost-benefit assessment covering cost benefit studies and industry opinion is a value-add for the report. The section provides a guideline to the stakeholders in understanding the investment structure and the cost-savings achieved using each type of robot.

Protein Expression Market | Business Overview, Products and Services, Key Insights, Recent Developments

According to the new market research report "Protein Expression Market by Type (E. Coli, Mammalian, Yeast, Pichia, Insect, Baculovirus, Cell-free), Products (Competent Cells, Reagents, Instruments, Services), Application (Therapeutic, Research, Industrial) & End User - Global Forecast to 2022 ", published by MarketsandMarkets™, is expected to reach USD 2,850.5 Million by 2022 from USD 1,654.0 Million in 2017, at a CAGR of 11.5% during the forecast period. 

The prevalence of chronic diseases, increasing research activities on recombinant-based proteins, and growing life sciences & biopharmaceutical industries are the major factors driving the growth of this market.

Download PDF Brochure:

https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=180323924

By systems type, the prokaryotic expression systems segment is expected to dominate the market in 2017

On the basis of systems type, the protein expression market is segmented into prokaryotic expression systems; insect cell expression systems; mammalian cell expression systems; yeast expression systems; cell-free expression systems; and algal-based expression systems.

The prokaryotic expression systems segment has been sub-segmented into Escherichia coli (E. coli) systems and other systems. The E. coli systems segment accounted for the largest share of this market segment. This growth can be attributed to the increasing use of E. coli systems for the production of commercial proteins.

Browse and in-depth TOC on "Protein Expression Market"

127 - Tables

38 - Figures

173 - Pages

By product, the reagents segment is expected to hold the largest share of the market in 2017

The market is segmented into competent cells, expression vectors, instruments, reagents, and services on the basis of products. The reagents segment holds the largest share and also expected to grow at the highest growth rate during the forecast period. This positive growth trend is primarily attributed to increasing research activities and large-scale production of antibodies and vaccines that require kits and reagents.

The therapeutic applications segment is expected to dominate the market in 2017

By application, the market is segmented into therapeutic applications, research applications and industrial applications.The therapeutic applications segment holds the largest share in the market; however, the research applications segment is expected to grow at the highest growth rate during the forecast period. Growth in the research applications segment is primarily attributed to the increase in proteomics-based research activities around the world.

By end user, the pharmaceutical and biotechnology companies segment is expected to hold the largest share of the market in 2017

On the basis of end users, the protein expression market is segmented into academic research institutes; contract research organizations (CROs); pharmaceutical and biotechnology companies; and other end users (food processing industry, detergent manufacturers, paper industry, leather industry, breweries, dairy industry, chemical industry, bioplastic industry, and cosmeceutical industry).The pharmaceutical and biotechnology companies segment holds the largest share in the market; however, the CROs segment is expected to grow at the highest growth rate during the forecast period.

Request Research Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=180323924

Asia offers lucrative growth opportunities

By region, the global market is segmented into North America, Europe, Asia, and the Rest of the World (RoW). While North America holds the largest share of the market in 2016, Asia is expected to grow at the highest CAGR during the forecast period. The presence of emerging economies like China and India; the large population and rising prevalence of chronic diseases in these countries; a growing demand of biologics; and the improving life sciences research infrastructure are the major factors driving the growth of this regional segment.

Key players operating in the protein expression market include Merck KGaA (Germany), Thermo Fisher Scientific Inc. (U.S.), Becton, Dickinson & Company (U.S.), Agilent Technologies, Inc. (U.S.), QIAGEN N.V. (Netherlands), Takara Bio Inc. (Japan), Lonza Group Ltd. (Switzerland), Bio-Rad Laboratories, Inc. (U.S.), GenScript Biotech Corporation (China), Lucigen Corporation (U.S.), Synthetic Genomics Inc. (U.S.)

Track and Trace Solutions Market Size, Share, Growth Drivers, Industry Analysis and Application Forecast 2023

The major factors driving the growth of this Track and Trace Solutions Market include the stringent regulations & standards for the implementation of serialization, increasing focus of manufacturers on brand protection, increasing number of packaging-related product recalls, high growth in the generic and OTC markets, and the growing medical device industry.

What the Market Looks Like?

The Global Market Predicted to grow at a CAGR of 14.2% during the forecast period, the Global Track and Trace Solutions Market is estimated to reach USD 4.21 billion by the end of 2024. In 2018, North America held the largest market share, followed by Europe and Asia-Pacific. However, Asia-Pacific is expected to register the fastest growth over the forecast period.

Based on types of software, the market is segmented into plant manager, line controller, enterprise & network manager, bundle tracking, warehouse & shipment manager, case tracking, and pallet tracking software. The plant manager segment accounted for the largest market share in 2018. The rising need to secure the supply chain of pharmaceutical and medical devices manufacturing industries along with strict government legislation are the key factors driving the growth of the plant manager segment.

Download PDF (Please provide your specific interest in this report so as to help you better) @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=158898570

On the basis of technology, the Track and Trace Solutions Market is segmented into linear barcodes, 2D barcodes, and Radio Frequency Identification (RFID). The 2D barcodes segment accounted for the largest market share in 2018. 2D barcodes are preferred for packaging over linear barcodes as they have a higher data storage capacity and contain large amounts of data with fewer variations in image size. This is a major factor driving the market for 2D barcodes.

Based on application, the market is segmented into serialization, aggregation, and tracking, tracing, and reporting solutions. The tracking, tracing, & reporting solutions segment is expected to register the highest CAGR during the forecast period. The high growth of this segment is attributed to the increasing number of regulations such as DSCSA, UDI, and Medical Device Reporting (MDR) for medical devices and pharmaceutical products.

What Drives the Market?

The growth of the global market for Track and Trace Solutions is primarily influenced by the following factors:

·         Stringent Regulations & Standards for the Implementation of Serialization

·         Increasing Focus of Manufacturers on Brand Protection

·         Growth in the Number of Packaging-Related Product Recalls

·         High Growth in the Generic and OTC Markets

·         Growth in the Medical Device Industry

Geographical growth scenario of Track and Trace Solutions Market:

North America accounted for the largest share of the market in 2018, followed by Europe. Factors such as the presence of many pharmaceutical & biotechnology companies and medical device manufacturers, stringent regulations regarding serialization, and the growing medical devices market, are driving the growth of the market in North America.

Request Research Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=158898570

Leading market players and strategies adopted:

The prominent players in the Track and Trace Solutions Market include OPTEL Group (Canada), Mettler-Toledo International Inc. (US), Systech International Inc. (US), TraceLink Inc. (US), Antares Vision (Italy), SAP (US), Xyntek Inc. (US), Adents International (France), SEA Vision Srl (Italy), Robert Bosch (Germany), Körber Medipak Systems AG (Switzerland), Siemens AG (Germany), Uhlmann Group (Germany), Jekson Vision (India), Videojet Technologies, Inc. (US), Zebra Technologies Corporation (US), Axway Inc. (US)

Body Composition Analyzers Market Growth Opportunity and Industry Forecast

Body composition analysis is the process to evaluate the amount of fat, muscle, and bone in the body. It gives the precise measurement of body fat in relation to lean body mass. Evaluation of body composition is essential in order to determine the risks associated with high or low levels of body fat. The growth of the overall Body Composition Analyzers market can be contributed to rise in obese population across the globe, growing health and fitness consciousness among people, increasing government initiatives to encourage physical activity and technological advancements.

According to the new market research report "Body Composition Analyzers Market by Product (Bio-impedance analyzer/DEXA/Skinfold calipers/ADP/Hydrostatic weighing), & End-users (Hospitals/Fitness & wellness centers/Academic & Research Center/Home-users) - Analysis & Global Forecasts", published by MarketsandMarkets™.

Revenue Growth Opportunities:

Body Composition Analyzers Market is projected to reach $668.16 Million, growing at a CAGR of 12.7%, during the forecast period.

Download PDF (Please provide your specific interest in this report so as to help you better): https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=248209133

Market Segmentation in-Detailed:-

The key drivers in the market are growing obese population, growing health and fitness consciousness among people, increasing government initiatives to encourage physical activity and technological advancements.

Based on product, the market is segmented into bio-impedance analyzer, dual energy X-ray absorptiometry (DEXA), skin fold Calipers, air displacement plethysmography (ADP) and hydrostatic weighing. The bio-impedance analyzer is expected to account for the largest share of the market, by product in 2016 and is expected to grow at highest CAGR.  This large share can be attributed to the simplicity, low cost, and better accuracy as compared to other body composition analyzers.

Based on end users, the market is segmented into hospitals, fitness clubs and wellness centers, academic and research centers. In 2016, hospitals segment is estimated to account for the largest share of the body composition analyzer market, by end-users in 2016 and is expected to grow at highest CAGR. The growth of this segment can be attributed to the rise in osteoporosis cases, increasing adoption of body composition analyzers to assess the nutritional status in patients and increasing health consciousness among masses.

Request Research Sample Pages:

https://www.marketsandmarkets.com/requestsampleNew.asp?id=248209133

Worldwide Geographical Segmentation in-detailed:

The Body Composition Analyzers Market is segmented into four regional segments, namely, North America, Europe, the Asia Pacific, and the Rest of the World. North America is expected to account for the largest share of the body composition analyzer market. Its large share can be attributed to rising obesity rates and increasing health clubs and fitness centers in the U.S. However, the Asia-Pacific market is slated to grow at the highest CAGR during the forecast period due to rising trend of overweight and obesity in China, and foothold of local players in Japan.

Leading Key Players in the Worldwide Industry:

The major players operating in the Body Composition Analyzers Market are InBody Co., Ltd (South Korea), Tanita Corporation (Japan), Omron Corporation (Japan), Hologic, Inc. (U.S.) and GE Healthcare (U.S.) among others.